why choose us

First received: September 09, 2022

Clinical Trial: External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Chronic Pain

Study Type: INTERVENTIONAL


Official Title: External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes

Brief Summary: This is a prospective, longitudinal, single-center, non-randomized, open-label, post-market clinical feasibility study to assess the efficacy of neuromodulation therapies (SCS and DRG) for chronic pain patients with diabetes and investigate whether physical and physiological data collected from diabetic and pre-diabetic chronic pain patients is predictive of subjective patient-reported outcomes (PROs) and of adjustments in patient care.These assessments will be made prior to, during, and after the trial of the SCS…

Read more